Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$86,042,693
-$194,800,927 QoQ
Shares Held
1,425,492
-70.5% QoQ
Ownership
1.47%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#18
of 314 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 82%
None 18%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. XENE ranks #38 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in XENE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,042,693 | 1,425,492 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $86,042,697 | 1,425,492 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $280,843,620 | 4,829,641 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $213,557,390 | 4,764,779 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $144,935,755 | 3,609,857 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $68,070,017 | 2,174,761 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $127,127,557 | 3,789,197 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $148,082,349 | 3,777,611 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $151,316,505 | 3,843,447 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $149,262,336 | 3,828,221 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $168,844,596 | 3,922,058 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $191,731,840 | 4,162,654 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $59,032,167 | 1,728,108 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $40,465,463 | 1,051,051 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,855,768 | 247,437 | Shares | Defined | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||